Effects of supplementing with Saccharomyces boulardii on vonoprazan–amoxicillin dual therapy for naive Helicobacter pylori infection: a randomized controlled trial

Abstract Background and aims This randomized controlled trial (RCT) sought to investigate whether Saccharomyces boulardii (S. boulardii) can improve the Helicobacter pylori (H. pylori) eradication rate and reduce adverse events when added to the vonoprazan–amoxicillin dual therapy—a first-line treat...

Descrición completa

Detalles Bibliográficos

Principais autores:	Zexuan Ji, Dingni Qu, Yonghao Feng, Xiangrong Qin, Xiaoyong Wang
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2026-04-01
Series:	BMC Gastroenterology
Assuntos:	Helicobacter pylori Saccharomyces boulardii Vonoprazan Dual therapy Randomized controlled trial
Acceso en liña:	https://doi.org/10.1186/s12876-026-04865-8
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!